Literature DB >> 11113053

Trypanosoma cruzi-infected cardiomyocytes produce chemokines and cytokines that trigger potent nitric oxide-dependent trypanocidal activity.

F S Machado1, G A Martins, J C Aliberti, F L Mestriner, F Q Cunha, J S Silva.   

Abstract

BACKGROUND: The pathogenesis of myocarditis that occurs in Trypanosoma cruzi-infected mice is still poorly understood. Therefore, it is important to know the mediators that trigger leukocyte migration to the heart as well as the cellular source of these possible mediators. In this study, we investigated (1) NO synthase (NOS) induction, (2) NO synthesis, (3) trypanocidal activity, and (4) chemokine and cytokine mRNA expression by isolated cardiomyocytes infected with T cruzi. METHODS AND
RESULTS: Mouse cardiomyocytes were isolated, infected with T cruzi, and evaluated for induction of inducible NOS (iNOS), nitrite production, trypanocidal activity, and cytokine and chemokine mRNA expression. We found that T cruzi-infected murine embryonic cardiomyocytes produced nitrite and expressed mRNAs for the chemokines chemokine growth-related oncogene, monokine induced by interferon-gamma, macrophage inflammatory protein-2, interferon-gamma-inducible protein, RANTES, and monocyte chemotactic protein, for iNOS, and for the cytokines tumor necrosis factor (TNF)-alpha and interleukin (IL)-1beta. Separate addition of IL-1beta, interferon-gamma, TNF-alpha or monocyte chemotactic protein, macrophage inflammatory protein-2, and interferon-gamma-inducible protein, to cultured cardiomyocytes resulted in NO production but low trypanocidal activity. However, simultaneous addition of IL-1beta, interferon-gamma, and TNF-alpha or the chemokines to cultures resulted in the induction of iNOS, high levels of nitrite, and a marked trypanocidal activity. The iNOS/L-arginine pathway mediated the latter activity, inasmuch as it was inhibited by treatment with N:(G)-monomethyl-L-arginine.
CONCLUSIONS: These results indicate that iNOS activation and the proinflammatory cytokines and chemokines produced by cardiomyocytes are likely to control parasite growth and cell influx, thus contributing to the pathogenesis of chagasic cardiomyopathy seen in T cruzi-infected mice.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11113053     DOI: 10.1161/01.cir.102.24.3003

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  89 in total

1.  Role of CCL3/MIP-1alpha and CCL5/RANTES during acute Trypanosoma cruzi infection in rats.

Authors:  Ester Roffê; Fabiano Oliveira; Adriano L S Souza; Vanessa Pinho; Danielle G Souza; Patrícia R S Souza; Remo C Russo; Helton C Santiago; Alvaro J Romanha; Herbert B Tanowitz; Jesus G Valenzuela; Mauro M Teixeira
Journal:  Microbes Infect       Date:  2010-05-07       Impact factor: 2.700

2.  New drugs for neglected infectious diseases: Chagas' disease.

Authors:  Fabiana S Machado; Herbert B Tanowitz; Mauro M Teixeira
Journal:  Br J Pharmacol       Date:  2010-05       Impact factor: 8.739

3.  Crucial role of the central leptin receptor in murine Trypanosoma cruzi (Brazil strain) infection.

Authors:  Fnu Nagajyothi; Dazhi Zhao; Fabiana S Machado; Louis M Weiss; Gary J Schwartz; Mahalia S Desruisseaux; Yang Zhao; Stephen M Factor; Huan Huang; Chris Albanese; Mauro M Teixeira; Philipp E Scherer; Streamson C Chua; Herbert B Tanowitz
Journal:  J Infect Dis       Date:  2010-10-01       Impact factor: 5.226

4.  Inflammatory and cardiac biomarkers are differentially expressed in clinical stages of Chagas disease.

Authors:  S M Keating; X Deng; F Fernandes; E Cunha-Neto; A L Ribeiro; B Adesina; A I Beyer; P Contestable; B Custer; M P Busch; E C Sabino
Journal:  Int J Cardiol       Date:  2015-07-12       Impact factor: 4.164

5.  Mast cell function and death in Trypanosoma cruzi infection.

Authors:  Marcelo Meuser-Batista; José Raimundo Corrêa; Vinícius Frias Carvalho; Constança Felícia De Paoli de Carvalho Britto; Otacilio da Cruz Moreira; Marcos Meuser Batista; Maurílio José Soares; Francisco Alves Farias Filho; Patrícia Machado R E Silva; Joseli Lannes-Vieira; Robson Coutinho Silva; Andrea Henriques-Pons
Journal:  Am J Pathol       Date:  2011-08-03       Impact factor: 4.307

6.  Intracellular growth of Trypanosoma cruzi in cardiac myocytes is inhibited by cytokine-induced nitric oxide release.

Authors:  Laura Edith Fichera; Maria Cecilia Albareda; Susana Adriana Laucella; Miriam Postan
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

7.  Nitric oxide synthase-2 modulates chemokine production by Trypanosoma cruzi-infected cardiac myocytes.

Authors:  Fabiana S Machado; Janeusa T Souto; Marcos A Rossi; Lisia Esper; Herbert B Tanowitz; Julio Aliberti; João S Silva
Journal:  Microbes Infect       Date:  2008-10-08       Impact factor: 2.700

8.  Parasite-derived neurotrophic factor/trans-sialidase of Trypanosoma cruzi links neurotrophic signaling to cardiac innate immune response.

Authors:  Ryan Salvador; Daniel Aridgides; Mercio PereiraPerrin
Journal:  Infect Immun       Date:  2014-06-16       Impact factor: 3.441

9.  The absence of myocardial calcium-independent phospholipase A2γ results in impaired prostaglandin E2 production and decreased survival in mice with acute Trypanosoma cruzi infection.

Authors:  Janhavi Sharma; Christopher S Eickhoff; Daniel F Hoft; David A Ford; Richard W Gross; Jane McHowat
Journal:  Infect Immun       Date:  2013-02-19       Impact factor: 3.441

10.  Inhibition of cyclooxygenase-1 and cyclooxygenase-2 impairs Trypanosoma cruzi entry into cardiac cells and promotes differential modulation of the inflammatory response.

Authors:  Aparecida D Malvezi; Carolina Panis; Rosiane V da Silva; Rafael Carvalho de Freitas; Maria I Lovo-Martins; Vera L H Tatakihara; Nágela G Zanluqui; Edecio Cunha Neto; Samuel Goldenberg; Juliano Bordignon; Sueli F Yamada-Ogatta; Marli C Martins-Pinge; Rubens Cecchini; Phileno Pinge-Filho
Journal:  Antimicrob Agents Chemother       Date:  2014-08-04       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.